Polyclonal Genomic Antibodies®

Polyclonal Genomic Antibodies® are available in 5 forms. Choose your Genomic Antibody Technology™ here:

Product Days from Receipt
of Sequence to Shipment
of Product		 Price
160 mL of Rabbit Sera 76 Please Call
300 mL of Rabbit Sera 90 Please Call
Affinity Purified Rabbit Antibody from 160 mL of Sera 90 Please Call
Affinity Purified Rabbit Antibody from 300 mL of Sera. 110 Please Call
1.0 mL of Mouse Sera 76 Please Call


Important Information

  • No additional antisera or affinity purified antibody will be available upon project initiation.

  • In SDI's experience:
         o 13% of 160 mL affinity purification packages yield less than 1 mg of antibody
         o 47% of 160 mL affinity purification packages yield between 1 to 6 mgs of antibody
         o 40% of 160 mL affinity purification packages yield between 6 to 14 mgs of antibody

  • A variety of factors can impact antibody yield. In some cases, immunogens with high homology may have lower antibody yield due to immune tolerance.

  • A 1:10,000 dilution is recommended as a starting point for Western blot. The recommended dilution range is 1:5,000 - 1:20,000 based on 1 mg/ml antibody concentration.

  • For 160 mL AP, the average endpoint titer is 0.92 ng/mL (on protein fragment, variable depending upon user format)

  • For 160 mL antisera, the average titer is 178,191 (on protein fragment, variable depending upon user format).

  • All work is fee-for-service.
    • Ready to Order?

    You can order Genomic Antibody Technology™ online by submitting your genetic sequence using your STAR Account. You can use a purchase order or your credit card to order online today.

    Sign in to your STAR Account, or register to create one.

    The latest from SDI Antibodies

  • SDI Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for use in Cancer Research. more more

  • SDI to Produce Library of Antibodies for the Study of Usher Syndrome. more more

  • SDI Enters Supply Agreement for Antibody Library for Study of Chromosome Proteins with University of North Carolina Chapel Hill more more

  • SDI Announces Progress in Advancing Clinical Biomarker Discovery, Successful Application of Technology in Cancer Biomarker Identification at M.D. Anderson Cancer Center more more

  • Strategic Diagnostics Inc. Announces Partnership with the University of Delaware and the Helen F. Graham Cancer Center to Develop Cancer Assays more more

  • SDI Announces Success in Demonstrating Utility of its Proprietary Genomic Antibody Technology™ Reagents on Clinical Samples in Cooperation with the Human Protein Atlas more more
    • Attend a Genomic Antibody Technology™ Webinar.
    • More dates coming soon.

    To register, send a message to GATWebinar@sdix.com